Learn More About the COVID-19 Vaccines and ITP
The Platelet Disorder Support Association recently recorded a patient education webinar on the new COVID-19 vaccines and immune thrombocytopenic purpura (ITP)
As part of a patient education webinar series known as ITP INSIGHTSSM, the Platelet Disorder Support Association (PDSA) recently recorded a session on the new COVID-19 vaccines and immune thrombocytopenic purpura (ITP), a disorder characterized by low platelet levels. The topic is especially timely as individuals affected by bleeding and platelet disorders continue to voice concerns and questions related to media reports of vaccine side effects, particularly those related to ITP. It should be noted that there have been an extremely small number of verified cases of severe ITP post vaccination, amongst the tens of millions of individuals who have been immunized against COVID-19.
Visit the PDSA website to learn more and to watch the webinar. The session COVID-19 & ITP: Viruses and Vaccines – How They Can Affect Platelets is free and readily accessible.
Source: National Hemophilia Foundation